Weight Management Semaglutide research peptide for qualified laboratory use in Canada
The tirzepatide drugs, such as Mounjaro and Zepbound, target the GLP-1 pathway along with a second one, the GIP pathway
Individuals with a history of certain medical conditions should avoid using it
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
For optimal results, apply over lipstick for a gloss-like finish
Although their proposed GLP1-based pill had to be scrapped earlier this year following evidence of liver toxicity in a Phase III trial 12 , Pfizer has recently acquired Metasera, a biopharmaceutical company specialising in obesity therapeutics